The effect of perioperative oral management on the outcomes in patients diagnosed as sarcopenia with hepato-biliary-pancreatic cancers.

The effect of perioperative oral management on the outcomes in patients diagnosed as sarcopenia with hepato-biliary-pancreatic cancers. - OMSA-HBP

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000031142

Enrollment

150

Registered

2018-04-01

Start date

2018-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver cancer, biliary tract cancer, pancreatic cancer

Interventions

Perioperative oral management

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients diagnosed as sarcopenia with hepato-biliary-pancreatic cancers who will undergo the operation.

Exclusion criteria

Exclusion criteria: The patients who have allergies for contrast media of CT or cannot take the CT examination because of severe renal dysfuncion. The patients with more than 2 in perfoemance status

Design outcomes

Primary

Measure	Time frame
Postoperative complication Hospital death The days of Hospitalization stay after the operation	—

Secondary

Measure	Time frame
Overall survival at one year and two yaers after the operation. Recurrence free survival at one year and two yaers after the operation.	—

Countries

Japan

Contacts

Public ContactIkuo Nakamura

Hyogo College of Medicine The department of Hepato-Bliary-Pncreatic surgery

shatano@hyo-med.ac.jp0798-45-6582

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026